Clinical Trial
Perennial rhinitis treated with a new steroid: fluocortin butylester (FCB)
- PMID: 3534992
Item in Clipboard
Clinical Trial
Perennial rhinitis treated with a new steroid: fluocortin butylester (FCB)
Rhinology.
1986 Sep.
Abstract
The effect of fluocortin butylester (FCB) in the topical treatment of perennial rhinitis was investigated in a double-blind study using a cross-over technique. The daily dose was 4 mg. Of the 30 patients who completed the trial, 26 had either allergy or nasal eosinophilia. 20 of the 30 patients preferred FCB to placebo. Moreover, there was a positive, but not statistically significant, therapeutic effect according to the patient score cards (0.1 less than p less than 0.2). In other words, the results are positive, but not definite. It is concluded that possibly the dose ought to be increased to obtain a more reliable effect.
Similar articles
-
Grass pollen-induced hay fever treated with a new steroid fluocortin butylester (FCB).Rhinology. 1983 Sep;21(3):257-63. Rhinology. 1983. PMID: 6356306 Clinical Trial.
-
The protective action of fluocortin butylester (FCB) in the nasal antigen provocation test: a controlled double-blind, crossover study.Ann Allergy. 1982 May;48(5):305-8. Ann Allergy. 1982. PMID: 7044195 Clinical Trial.
-
Efficacy and tolerance of fluocortin butyl administered twice daily in adult patients with perennial rhinitis.J Allergy Clin Immunol. 1985 Apr;75(4):501-7. doi: 10.1016/s0091-6749(85)80024-5. J Allergy Clin Immunol. 1985. PMID: 3884690 Clinical Trial.
-
Multi-center, double-blind, placebo-controlled trial of fluocortin butyl in perennial rhinitis.J Allergy Clin Immunol. 1983 Jun;71(6):597-603. doi: 10.1016/0091-6749(83)90442-6. J Allergy Clin Immunol. 1983. PMID: 6343462 Clinical Trial.
-
[Clinical trial of fluocortin butylester in a double-blind contralateral comparison versus fluocortolone and hydrocortisone acetate (author's transl)].Arzneimittelforschung. 1977;27(11a):2240-4. Arzneimittelforschung. 1977. PMID: 341901 Clinical Trial. German.